300601 Share Price Performance
CN¥14.44
-0.85 (-5.56%)
Price CN¥14.44
Share Pricen/a
Shenzhen Kangtai Biological Products Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
300601 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Shenzhen Kangtai Biological Products Co., Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 22, 2026
- -0.09
- 66.37%
- -3.72%
- 19.5%
About 300601
- Founded
- 1992
- Employees
- 1913
- CEO
- WebsiteView website
Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. The company’s marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanus and acellular pertussis combined vaccine, adsorbed, rabies vaccine (human diploid cell) for human use, hib conjugate vaccine, measles and rubella combined vaccine, sars-cov-2 vaccine, inactivated, and covid-19 vaccine. Its research and development vaccines comprise measles, mumps and rubella vaccine, 2DTAP- HIB-IPV, 4-valent influenza (split), poliomyelitis vaccine (vero cells), and inactivated, sabin strain. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.
